GENE-BASED PREDICTION OF PSA RECURRENCE FOR CLINICALLY LOCALIZED PROSTATE CANCER PATIENTS.

摘要

Disclosed are methods, devices and kits for determining the likelihood of recurrence of prostate cancer using the expression levels of preferably three-gene classifier. The methods, devices and kits can be used independent of many nomograms currently in use or to improve the overall performance of such nomograms.